Oxford BioMedica plc, of Oxford, UK, disclosed details of a proposed share issue to raise gross proceeds of £16 million (US$24.8 million) £14.5 million net of expenses by way of placing 440 million new ordinary shares priced at 1 pence apiece and an open offer of up to 201 million shares priced at 2.5 apiece.
Suite: 1100 | Atlanta, Georgia 30346, USA
Outside of the US
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
Sign up for Highlights FREE e-mail newsletter